Related Experiment Video
Updated: Aug 28, 2025
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Cardiovascular biomarkers improve precise risk assessment for cardiovascular diseases]
1Center of Laboratory Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences, No.167, Beilishi Rd, XiCheng District, Beijing 100037, China.
Insights
Cardiovascular disease (CVD) risk assessment in China is improving. Novel tools using cardiovascular biomarkers offer better prediction than traditional methods, aiding precise risk management.
Area of Science:
- Cardiology
- Public Health
- Biomarker Research
Background:
- Cardiovascular diseases (CVD) pose a significant public health threat in China.
- Traditional CVD risk assessment tools have limitations in accuracy and specificity.
- Effective risk assessment is crucial for managing cardiovascular health.
Purpose of the Study:
- To review limitations of traditional CVD risk assessment tools.
- To evaluate the application value of novel CVD risk assessment tools.
- To discuss advances in cardiovascular biomarkers for CVD prediction.
Main Methods:
- Literature review of clinical trials and studies on CVD risk assessment.
- Analysis of traditional versus biomarker-based risk prediction methods.
- Evaluation of the impact of novel tools on CVD risk stratification.
Main Results:
- Cardiovascular biomarkers significantly enhance the sensitivity and specificity of CVD risk prediction.
- Novel risk assessment tools show promise for improved patient management.
- Biomarker-based approaches facilitate precise stratification of the general population.
Conclusions:
- Advances in cardiovascular biomarkers offer superior CVD risk prediction.
- Novel assessment tools are essential for precise risk stratification and management.
- Implementing these advances supports the 'Healthy China' initiative.
Abstract:
Cardiovascular diseases (CVD) is an urgent threat to Chinese. It is of primary importance to assess risk for cardiovascular diseases. However, there are some limitations about traditional tools for CVD risk assessment. Recently, numbers of clinical trials demonstrated that CVD risk assessments based on cardiovascular biomarkers would significantly improve sensitivity and specificity of prediction. The comment review the limitations of traditional tools for CVD risk assessment, the application value of novel tools and advances of cardiovascular biomarkers in CVD prediction. It is benefit for precise stratification and management of general population during risk stage. Archieving the strategic goal of"Healthy China"would be promising soon.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease I: Introduction
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:26Coronary Artery Disease IV: Preventive Measures
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...